Business Wire - Onconase-anti-CD22 Monoclonal Antibody Conjugates Produce Signi
Posted on Tuesday, November 14 @ 08:00:00 CST by admin
November 14, 2000 -- Business Editors BLOOMFIELD, N.J.--(BUSINESS WIRE)--Nov. 14, 2000 Repeated Doses Can Be Safely Administered Systemically; Findings Suggest New Approach For Treatment of Non-Hodgkin's Lymphoma
Click Here to read the entire article...
|
| |
|